Advancing Diverse Representation in Clinical Trials and Research

HealthVerity offerings support the call for action by the Committee on Improving Representation of Women and Underrepresented Minorities in Clinical Trials and Research.

HealthVerity Patient Confidence Index (HVPCI) signals dramatic changes in patient behavior due to COVID-19

HealthVerity Patient Confidence Index (HVPCI) signals dramatic changes in patient behavior due to CO...

April 30, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity Patient Confidence In...

HVPCI sees its highest score as patients continue to seek care

July 9, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity Patient Confidence Inde...

Driving the new generation of value-based agreements

Value-based agreements unite pharma companies and payers with a mutually beneficial payment model, all while keeping the...

HealthVerity pulse: Q2 in review

Throughout the past quarter, we’ve announced major collaborations, built on existing partnerships and continued to suppo...

HealthVerity Patient Confidence Index (HVPCI) upgraded to Critical as physician visits rise sharply

June 25, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity Patient Confidence Ind...

Webinar recap: RWE and real-time insights in the COVID-19 era

During yesterday’s webinar, RWE and real-time insights: How to advance regulatory and commercial strategy in the COVID-1...

HealthVerity Patient Confidence Index (HVPCI) downgraded to Severe as telehealth visits diminish

June 11, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity Patient Confidence Ind...

Subscribe to the HealthVerity blog

Contact us